FDA Inspection 1174585 — Emcure Pharmaceuticals Limited
The FDA completed an inspection of Emcure Pharmaceuticals Limited on Jun 24, 2022 in Gandhinagar. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 24, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gandhinagar (India)
Additional Details
Postmarket Adverse Drug Experience (PADE)